Dolki Korea develops Salicid, portable medical device

Published: 2009-12-28 06:58:00

Updated: 2009-12-28 06:58:00

Dolki Korea Ltd., a local bioventure company, has developed a potable medical device Salicid, using a low concentration of hypochlorous acid (3-5 ppm) as medicinal use.

According to the company, hypochlorous acid of low concentration is safely applied to human mucosa and exhibits an antimicrob...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK